Biotangents Secures £326,000 in Equity Finance
Dec 21, 2017
Scottish based Biotangents Ltd are developing timely diagnostics to improve livestock welfare. Recently, the Company closed an equity financing round of £326,000 that will be used to progress their pen-side infectious disease test. The investment came from Kelvin Capital members and was supported by Innova Partnerships.
Commenting, Innova’s founder, Prof Steve Howell, said “The team at Biotangents have made significant progress over the last year and this investment will allow them to speed up product development.”
Biotangents CEO, Alan Hale, added “We have some exceptional individuals and founders, in Andy and Lina. Together, we are focussed on bringing to market cost-effective solutions to support livestock disease management and look forward to an exciting year ahead.”
The Company is currently located at the Pentlands Science Park just outside Edinburgh.
Unilever and Innova Partnerships One Step Closer to Self-Cleaning Surfaces
- Jan 05, 2021
Innova Partnerships Support Mologic Set Up COVID-19 Test Manufacturing Facility
- Apr 27, 2020
Innova Portfolio Company Completes £1.5M Oversubscribed Funding Round - Biotangents to Accelerate Roll Out of Livestock Disease Diagnostic Product
- May 06, 2019
Vitamica Announce Successful First Round of Funding
- Oct 10, 2018
Innova Partnerships Appointed by Invest Northern Ireland to Support Irish Company Growth
- Jun 01, 2018